Stay updated on Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FM-6VmXuZLl63jENQCNVLlCrexzE.uncropped.jpg&w=3840&q=75)
Latest updates to the Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check2 days agoNo Change Detected
- Check3 days agoNo Change Detected
- Check4 days agoChange DetectedThe study has been updated to version v2.10.0, replacing the previous version v2.9.7.SummaryDifference0.3%
- Check5 days agoNo Change Detected
- Check8 days agoChange DetectedThe website now displays actual posting dates for results and updates, instead of estimated dates.SummaryDifference0.1%
- Check9 days agoChange DetectedThe website has posted results for the overall response rate and safety of combination pembrolizumab and bavituximab in patients with advanced HCC, along with study documents provided by David Hsieh from the University of Texas Southwestern Medical Center.SummaryDifference4%
- Check11 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check25 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.SummaryDifference0.1%
- Check30 days agoChange DetectedThe value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent change in the webpage content.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial page.